ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P ASX 200
7,015.20
(
0.39%
)
S&P ASX All Technology
2,427.20
(
-0.14%
)
Brent Oil
80.845
(
1.01%
)
US Dollar vs AUD
1.51165
(
-0.04%
)
Bitcoin
37,033.72
(
-0.60%
)
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Xilio Therapeutics Inc (XLO)

  7. Xilio Therapeutics Inc (XLO) News

XLO Xilio Therapeutics Inc

1.11
0.00 (0.0%)
Pre Market
Last Updated: 20:20:50
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Xilio Therapeutics Inc XLO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.0% 1.11 20:20:50
Open Price Low Price High Price Close Price Previous Close
1.11
more quote information »

Recent News

Date Time Source Heading
10/11/202308:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202308:13EDGAR2Form 8-K - Current report
10/11/202308:10EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
10/11/202308:08EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
10/11/202308:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
10/11/202308:01GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
04/11/202307:05EDGAR2Form 8-K - Current report
04/11/202303:00GLOBEXilio Announces Initial Monotherapy Safety and Anti-Tumor..
01/11/202300:15GLOBEXilio to Host Virtual Investor Conference Call and Webcast..
28/9/202307:02GLOBEXilio Therapeutics Announces Upcoming Presentations at the..
08/9/202306:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202306:23EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/9/202322:35EDGAR2Form 8-K - Current report
05/9/202322:30GLOBEXilio Therapeutics Announces Promotion of Katarina..
05/9/202321:30GLOBEXilio Therapeutics to Present at Morgan Stanley 21st Annual..
19/8/202310:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202310:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202321:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202321:40EDGAR2Form 8-K - Current report
14/8/202321:30GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
08/8/202306:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202306:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/8/202306:15EDGAR2Form 8-K - Current report
04/8/202306:05GLOBEXilio Therapeutics Announces Promotion of Chris Frankenfield..
26/5/202307:01GLOBEXilio Therapeutics Announces Preliminary Clinical Data from..
09/5/202321:30GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
04/4/202306:05GLOBEXilio Therapeutics Announces Inducement Grant Under Nasdaq..
03/3/202308:05GLOBEXilio Therapeutics Announces Pipeline and Business Updates..
27/2/202323:30GLOBEXilio Therapeutics to Present at Upcoming Investor..
16/2/202323:30GLOBEXilio Therapeutics to Present at the Citi 2023 Virtual..
02/2/202323:30GLOBEXilio Therapeutics to Present at the Guggenheim Healthcare..

Your Recent History

NASDAQ
XLO
Xilio Therapeutics

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com